Mark A. Ozog

Zanidatamab, a novel bispecific antibody, for the treatment of locally advanced or metastatic HER2-expressing or HER2-amplified cancers: a phase 1, dose-escalation and expansion study

Funda Meric‐Bernstam, Muralidhar Beeram, Erika Hamilton et al. · The Lancet Oncology · 2022 · 182 citations · Full text

Medicine, Oncology, Pharmacology +17

CCN3 (NOV) Interacts with Connexin43 in C6 Glioma Cells

Christine Fu, John F. Bechberger, Mark A. Ozog et al. · Journal of Biological Chemistry · 2004 · 157 citations · Full text

Medicine, Neuroscience, Oncology +9

Blocked Gap Junctional Coupling Increases Glutamate-Induced Neurotoxicity in Neuron-Astrocyte Co-Cultures

Mark A. Ozog, Ramin Siushansian, Christian C. Naus · Journal of Neuropathology & Experimental Neurology · 2002 · 140 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Expression of connexins in embryonic mouse neocortical development

Cima Cina, John F. Bechberger, Mark A. Ozog et al. · The Journal of Comparative Neurology · 2007 · 98 citations

Life Sciences, Neurobiology, Neuroscience +16

A Neuroprotective Role for Gap Junctions

Christian C. Naus, Mark A. Ozog, John F. Bechberger et al. · Cell Communication & Adhesion · 2001 · 68 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17